Chimerix Inc. - Rasio nilai perusahaan marang dodolan CMRX

Simbol resmi perusahaan chimerix.com (CMRX)

The EV/Sales multiple dynamics for Chimerix, Inc. (CMRX) depend on government contracts and partnership payments for oncology therapy. The foundation is constrained by strict FDA oversight and R&D expenditures, while risks are concentrated on the outcome of imidazolinone tests. The current value of the metric demonstrates the market value of the business excluding debt, allowing for an assessment of the asset's resilience to external shocks through the lens of investor perception.

Chimerix Inc (CMRX): Nilai perusahaan marang pendapatan saka 04.07.2022 nganti 20.11.2026

Chimerix, Inc - rincian analitis lan metrik utama (CMRX)

Pambiji fundamental perusahaan:CMRX, chimerix.com
Produk sing diprodhuksi Chimerix Inc.

For Chimerix, Inc. (CMRX), with its focus on ONC201 clinical trials, current operating expenses are already priced into the market value. By analyzing the EV/Sales ratio, an investor sees the ratio of total enterprise value to revenue excluding debt, which allows for determining the degree of asset overvaluation relative to market norms and assessing the risk of a capital correction.

Analisis pesaing

Multiplikator nilai perusahaan marang pendapatan Incyte Corporation|HCM (HUTCHMED Corp) - Nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang dodolan Nuvation Pharma NUVB|Nilai perusahaan marang pendapatan DAWN|Multiplikator nilai perusahaan marang pendapatan Monopar Therapeutics MNPR|Nilai perusahaan marang pendapatan INBX (Inhibrx Biosciences)|IMAB (I-Mab Inc.) - Nilai bisnis marang pendapatan|Fennec Pharmaceuticals - Nilai perusahaan marang pendapatan|Koefisien nilai perusahaan marang pendapatan HRTX (Heron Therapeutics Inc)|Nuvectis - Multiplikator EV/Sales|Nilai bisnis marang pendapatan CHRS (Coherus BioSciences Inc.)|CRBP: Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan Cardiff Oncology Corp (CRDF)|Rasio nilai perusahaan marang pendapatan BeyondSpring|BCAB: Nilai bisnis marang pendapatan|Multiplikator EV/Sales LIXT|Multiplikator EV/Sales Citius Pharmaceuticals Inc. (CTXR)|Rasio nilai perusahaan marang pendapatan Cellectar CLRB|BLRX (BioLineRx) - Nilai perusahaan marang volume dodolan|CANF: Nilai perusahaan marang pendapatan|Multiplikator nilai perusahaan marang pendapatan aprea.com|Kazia Therapeutics Limited (KZIA) - Rasio nilai perusahaan marang pendapatan|SLXN - Rasio total nilai perusahaan marang pendapatan|Nilai perusahaan marang pendapatan NCNA|Multiplikator nilai perusahaan marang pendapatan Cyclacel Pharmaceuticals CYCC|G1 Therapeutics Inc. (GTHX) - Nilai bisnis marang pendapatan|KRON - Multiplikator nilai perusahaan marang pendapatan|Kintara Therapeutics, Inc. - Nilai perusahaan marang pendapatan|Koefisien nilai perusahaan marang pendapatan ONCT (Oncternal)|Portage Biotech Corp - Multiplikator EV/Sales